Senior Medical Science Liaison (Neurology) Northeast or Midwest Region

The role

The Senior Medical Science Liaison will support the advancement of the neuromuscular disease portfolio. This field-based role builds strategic relationships with key opinion leaders, investigators, healthcare professionals, and advocacy organizations.

What you will do

• Serve as the scientific expert for neuromuscular disease programs and maintain relationships with external stakeholders.
• Conduct compliant scientific exchange regarding disease state education, clinical data, unmet needs, and investigational therapies.
• Gather and communicate medical insights to inform Medical Affairs, Clinical Development, and commercialization strategies.
• Support clinical trials through investigator engagement, site identification, enrollment support, and protocol discussions.
• Represent Dianthus at scientific congresses, advisory boards, investigator meetings, and other external medical forums.
• Contribute to evidence generation, scientific communications, publications, and educational initiatives.
• Collaborate cross-functionally with Medical Affairs, Clinical Development, Clinical Operations, Regulatory Affairs, Market Access, and Commercial teams.
• Ensure all activities are conducted in compliance with regulatory, legal, and company requirements.

Required qualifications

• Advanced scientific or clinical degree (PharmD, PhD, MD, DO, or equivalent)
• 7+ years of pharmaceutical or biotechnology industry experience, including significant field medical experience
• Experience building relationships with neuromuscular, neurology, rare disease, or immunology thought leaders and investigators
• Strong understanding of clinical research, evidence generation, and scientific communications
• Excellent communication, presentation, and influencing skills
• Ability to work independently in a fast-paced, highly collaborative environment
• Willingness to travel extensively within the assigned territory

Nice to have

• Previous experience in neurology or immunology/inflammation

About the company

Dianthus Therapeutics is developing therapies for patients living with severe autoimmune diseases. Their portfolio includes candidates targeting C1s complement protein, Type 1 IFN suppression, B cell modulation, and BAFF/APRIL.